TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Du sparer 0% ift. normalprisen Spar 0%

Hardback
8-11 hverdage
1.716,95 kr.

Bag om TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy.

Vis mere

Sprog:
Engelsk

ISBN:
9783319568041

Forlag:
Springer International Publishing AG

Indbinding:
Hardback

Sideantal:
317

Udgivet:
10. juli 2017

Udgave:
12017

Vægt:
799 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 16. december 2024

På lager

Forlænget returret til d. 31. januar 2025

Normalpris

1.716,95 kr. + Fragt
~~1.716,95 kr.~~

Medlemspris

1.666,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy.

Brugerbedømmelser af TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Andre købte også..

Find lignende bøger

Bogen TRAIL, Fas Ligand, TNF and TLR3 in Cancer findes i følgende kategorier:

Business og læring

TRAIL, Fas Ligand, TNF and TLR3 in Cancer - Bog

Beskrivelse af TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Brugerbedømmelser af TRAIL, Fas Ligand, TNF and TLR3 in Cancer

Gør som tusindvis af andre bogelskere